Isatin oximes as inhibitors of respiratory syncytial virus fusion

被引：0
|
作者：
Venables, BL
Yu, KL
Pearce, BC
Zhang, Y
Combrink, K
Thuring, J
Wang, XA
Civiello, RL
Gulgeze, HB
Genovese, E
Cianci, C
Kadow, KF
Voss, S
Lamb, L
Medina, I
Clark, JM
Yang, Z
Zadjura, L
Huang, S
Krystal, M
Meanwell, NA
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Chem, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Virol, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Wallingford, CT 06492 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 230卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：U2609 / U2609
页数：1
相关论文
共 50 条
  • [21] Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
    Roymans, Dirk
    Alnajjar, Sarhad S.
    Battles, Michael B.
    Sitthicharoenchai, Panchan
    Furmanova-Hollenstein, Polina
    Rigaux, Peter
    Van den Berg, Joke
    Kwanten, Leen
    Van Ginderen, Marcia
    Verheyen, Nick
    Vranckx, Luc
    Jaensch, Steffen
    Arnoult, Eric
    Voorzaat, Richard
    Gallup, Jack M.
    Larios-Mora, Alejandro
    Crabbe, Marjolein
    Huntjens, Dymphy
    Raboisson, Pierre
    Langedijk, Johannes P.
    Ackermann, Mark R.
    McLellan, Jason S.
    Vendeville, Sandrine
    Koul, Anil
    NATURE COMMUNICATIONS, 2017, 8
  • [22] PURIFICATION AND CHARACTERIZATION OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN
    WALSH, EE
    BRANDRISS, MW
    SCHLESINGER, JJ
    JOURNAL OF GENERAL VIROLOGY, 1985, 66 (MAR): : 409 - 415
  • [23] Orally active fusion inhibitor of respiratory syncytial virus
    Cianci, C
    Yu, KL
    Combrink, K
    Sin, N
    Pearce, B
    Wang, A
    Civiello, R
    Voss, S
    Luo, GX
    Kadow, K
    Genovesi, EV
    Venables, B
    Gulgeze, H
    Trehan, A
    James, J
    Lamb, L
    Medina, I
    Roach, J
    Yang, Z
    Zadjura, L
    Colonno, R
    Clark, J
    Meanwell, N
    Krystal, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) : 413 - 422
  • [24] Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein
    McLellan, Jason S.
    CURRENT OPINION IN VIROLOGY, 2015, 11 : 70 - 75
  • [25] Purification of human respiratory syncytial virus fusion glycoprotein
    Zheng, Yanpeng
    Tang, Yaning
    Fu, Yuanhui
    He, Jinsheng
    Wang, Xiaobo
    Hong, Tao
    PROTEIN EXPRESSION AND PURIFICATION, 2012, 81 (01) : 115 - 118
  • [26] MAPPING OF A FUSION RELATED EPITOPE OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN
    PARADISO, PR
    HU, BT
    ARUMUGHAM, R
    HILDRETH, S
    VACCINE, 1991, 9 (04) : 231 - 237
  • [27] The Respiratory Syncytial Virus Fusion Protein and Neutrophils Mediate the Airway Mucin Response to Pathogenic Respiratory Syncytial Virus Infection
    Stokes, Kate L.
    Currier, Michael G.
    Sakamoto, Kaori
    Lee, Sujin
    Collins, Peter L.
    Plemper, Richard K.
    Moore, Martin L.
    JOURNAL OF VIROLOGY, 2013, 87 (18) : 10070 - 10082
  • [28] Inhibitors of respiratory syncytial virus fusion: Optimization from screening leads to potent, orally active compounds
    Meanwell, Nicholas A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [29] Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion Inhibitors
    Zheng, Xiufang
    Liang, Chungen
    Wang, Lisha
    Wang, Baoxia
    Liu, Yongfu
    Feng, Song
    Wu, Jim Zhen
    Gao, Lu
    Feng, Lichun
    Chen, Li
    Guo, Tao
    Shen, Hong C.
    Yun, Hongying
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (22) : 10228 - 10241
  • [30] Revealing the binding mode between respiratory syncytial virus fusion protein and benzimidazole-based inhibitors
    Ji, Dingjue
    Ye, Wei
    Chen, HaiFeng
    MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1857 - 1866
12345